Page 31 - CPG endometrial cancer
P. 31
26
แนวทางการตรวจคัดกรอง วินจิ ฉัยและรักษาโรคมะเร็งเย่ือบุโพรงมดลกู
14. Van Gool IC, Stelloo E, Nout RA, Nijman HW, Edmondson RJ, Church DN, et al. Prognostic significance of L1CAM
expression and its association with mutant p53 expression in high-risk endometrial cancer. Mod Pathol 2016;29(2):174-
181.
15. Jamieson A, Barroilhet LM, McAlpine JN. Molecular classification in endometrial cancer: Opportunities for precision
oncology in a changing landscape. Cancer 2022;128(15):2853-2857.
16. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. Uterine Neoplasm
Version 2.2023. 2023 Apr 28. [internet]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/uterine.pdf.
Accessed on September 23, 2023.
17. Murali R, Delair DF, Bean SM, Abu-Rustum NR, Soslow RA. Evolving Roles of Histologic Evaluation and molecular/genomic
profiling in the management of endometrial cancer. J Natl Compr Canc Netw 2018;16(2):201-209.
18. Talhouk A, McAlpine JN. New classification of endometrial cancers: the development and potential applications of genomic-
based classification in research and clinical care. Gynecol Oncol Res Pract 2016;3:14.
19. Casey L, Singh N. POLE, MMR, and MSI Testing in Endometrial Cancer: Proceedings of the ISGyP Companion Society Session
at the USCAP 2020 Annual Meeting. Int J Gynecol Pathol 2021; 40: 5-16.
